Medical News Software

Download | Private Label | Advertisers

 

 

 
Diabetes News

Featured Job

Vermont Home Health RN JK1000maNET - Southern - N/A (per year)
Mon, 17 Nov 2008 23:40:00 GMT
Home Health Registered Nurse for Vermont Home Health Care. Includes, but is not limited to cardiopulmonary assessment, medication teaching, wound care, and intravenous therapy. Medicare Home Health Ag...


XTL Biopharmaceuticals Announces Top-Line Results From The Bicifadine Phase 2b Study For Diabetic Neuropathic Pain
Wed, 19 Nov 2008 00:00:00 PST
XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB; TASE: XTL) announced the top-line results from the Bicifadine Phase 2b clinical trial for the treatment of diabetic neuropathic pain. The trial's primary objective was to compare the efficacy of two doses of Bicifadine against placebo in reducing pain associated with diabetic neuropathy. The primary endpoint of the study was the reduction in pain score during the course of treatment.

Study Finds Cost Of Diabetes In The United States Exceeds $217 Billion
Wed, 19 Nov 2008 00:00:00 PST
According to findings from a National Diabetes Economic Barometer study, undiagnosed, pre-diabetes and diabetes cost the United States an estimated $217.5 billion in 2007 due to higher medical expenditures and lost productivity. The research shows that beyond the estimated $174 billion that is widely-accepted as the cost of diagnosed diabetes in 2007, an additional $18 billion was spent on 6.

Why Should You Care About Diabetes? Kansas Department Of Health And Environment
Tue, 18 Nov 2008 08:00:00 PST
November is American Diabetes Month. To increase awareness of diabetes and its complications, the Kansas Department of Health and Environment (KDHE) and the American Diabetes Association (ADA) are asking the public "Why should you care about diabetes?" "Diabetes can lead to heart disease, stroke, kidney disease, blindness and amputations," said Roderick L. Bremby, Secretary of KDHE.

Type 1 Diabetes Prevented, Reversed By Two Cancer Drugs, UCSF Study Shows
Tue, 18 Nov 2008 08:00:00 PST
Two common cancer drugs have been shown to both prevent and reverse type 1 diabetes in a mouse model of the disease, according to research conducted at the University of California, San Francisco. The drugs - imatinib (marketed as Gleevec) and sunitinib (marketed as Sutent) - were found to put type 1 diabetes into remission in 80 percent of the test mice and work permanently in 80 percent of those that go into remission.

Statement From The American Diabetes Association On Court Ruling To Deny Care To Children With Diabetes
Tue, 18 Nov 2008 03:00:00 PST
The American Diabetes Association (ADA) is extremely disappointed with the recent California Superior Court ruling striking down a provision of an agreement between the ADA and the California Department of Education that would ensure students with diabetes are safe at school and during school activities. The provision at issue allowed for trained non-licensed school personnel in California to administer insulin when a nurse was not available.

News From Annals Of Internal Medicine, Nov. 18, 2008, Issue
Tue, 18 Nov 2008 03:00:00 PST
1. New ACP Guideline Looks at Effectiveness of Drugs Used to Treat Depressive Disorders Second generation treatments for depression are all equally effective according to a new clinical practice guideline from the American College of Physicians (ACP). The guideline is published today in Annals of Internal Medicine, the ACP's flagship journal.

Diabetes News



Home | Download |About Us | Advertisers | Partners | Private Label | Contact Us | Site Map | Help
MedReader.Com © | Privacy Policy | Terms of Use